4.7 Article

Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition

Related references

Note: Only part of the references are listed.
Article Oncology

Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51

Bingliang Wang et al.

CANCER BIOLOGY & THERAPY (2015)

Article Biotechnology & Applied Microbiology

Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells

Yu Wang et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)

Review Oncology

DNA repair dysregulation from cancer driver to therapeutic target

Nicola J. Curtin

NATURE REVIEWS CANCER (2012)

Article Biochemistry & Molecular Biology

Dietary Administration of Berberine or Phellodendron amurense Extract Inhibits Cell Cycle Progression and Lung Tumorigenesis

Michael A. James et al.

MOLECULAR CARCINOGENESIS (2011)

Review Oncology

Rethinking ovarian cancer: recommendations for improving outcomes

Sebastian Vaughan et al.

NATURE REVIEWS CANCER (2011)

Review Pathology

Ovarian Cancer

Kathleen R. Cho et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)

Article Biotechnology & Applied Microbiology

Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage

Zhaojian Liu et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)

Article Pharmacology & Pharmacy

Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation

Syed M. Meeran et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)

Article Multidisciplinary Sciences

TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination

Zhiyong Mao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

H Farmer et al.

NATURE (2005)

Article Biochemistry & Molecular Biology

A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage

SF El-Khamisy et al.

NUCLEIC ACIDS RESEARCH (2003)